From Genetic Tests to Tailored Care: Decoding a field with big potential -- and even bigger implications
By Kelly Bothum,
Delaware Online
| 06. 01. 2010
[Quotes CGS's Jesse Reynolds]
Imagine a doctor using your genetic profile to decide which medicine to prescribe or to determine your risk for developing a life-threatening health problem. It's not a medical fantasy -- genetic tests already are used to gauge how patients will respond to certain drugs or to look for mutations in specific genes that can increase the risk for developing aggressive types of cancer.
But while the potential of so-called personalized medicine seems immense, some big questions are years away from being fully answered. Right now, researchers are still trying to understand key issues related to this next frontier of modern medicine, including how genetic profiling can help patients better understand their health risks, how medical professionals will be able to interpret results and what, if any, ethical implications arise in having this much genetic information.
"Personalized medicine is still in its infancy," said Dr. Ayyappan Rajasekaran, director of the Nemours Center for Childhood Cancer Research, which is studying biomarkers that can help identify more aggressive forms of the disease in kids. "We have a chance to do fantastic work."
At...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...